Vastagbélrák: vizsgálatok itt: Franciaország
184 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- Where
- Lyon, Montpellier, Paris, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT06004245 · EU 2023-503170-20-01 - 3. fázisTaking peopleA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Where
- Angers, Avignon, Caen Cedex 5, Limoges, Nice, Paris, Reims, Rouen, Toulouse Cedex 9, Vandoeuvre Les Nancy Cedex
- Életkor
- 18 év and over
- People
- 477 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Angers, Limoges Cedex I, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Where
- Lyon, Marseille, Paris
- Életkor
- 18 év and over
- People
- 616 worldwide
- Run by
- Verastem, Inc.
See details and how to joinNCT07020221 - No phaseTaking peopleAnalysis of Circulating Tumor Markers in Blood
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 992
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT04025541 - No phaseNot yet taking people in FranciaországMultidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 115
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT07404228 - 1/2. fázisTaking peopleBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Where
- Bordeaux, Caen, Lyon, Marseille, Paris, Rennes, Saint-Herblain, Strasbourg, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 910 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06324357 - 3. fázisTaking peoplePhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Where
- Bordeaux, Lille, Lyon, Marseille, Montpellier, Nancy, Nantes, Nice, Paris, Pierre-Bénite, Poitiers, Reims, Strasbourg, Villejuif
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07228832 - 1. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Where
- Poitiers, Villejuif Cedex
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- Pfizer
See details and how to joinNCT07318805 · EU 2025-524387-38-00 - 3. fázisTaking peopleA Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Where
- Bordeaux, Caen Cedex 5, Lille Cedex, Lyon, Marseille, Paris, Saint-Priest-en-Jarez, Villejuif
- Életkor
- 18 év and over
- People
- 1020 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412 · EU 2025-524648-37-00 - 1. fázisTaking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Lyon, Saint-Herblain Cedex, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - 2. fázisTaking peopleRegorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
- Where
- Auxerre, Besançon, Chalon-sur-Saône, Colmar, Dijon, Lyon, Metz, Montbéliard, Montpellier, Nancy, Reims, Strasbourg
- Életkor
- 18 év and over
- People
- 174
- Run by
- Centre Hospitalier Universitaire de Besancon
See details and how to joinNCT06425133 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Bordeaux, Brest, Lille, Montpellier, Pierre-Bénite, Villejuif
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 1. fázisTaking peopleA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Where
- Paris, Saint-Herblain
- Életkor
- 18 év and over
- People
- 421 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00 - 3. fázisTaking peopleA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Where
- Avignon Cedex 9, Lille, Lyon, Montpellier Cedex 5, Nantes, Paris, Pessac, Poitiers, Villejuif
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06662786 · EU 2024-513852-13-00 - 3. fázisTaking peopleA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Where
- Avignon Cedex 9, Pessac, Poitiers
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06750094 · EU 2024-513853-66-00 - 1/2. fázisTaking peopleA Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Where
- Bordeaux, Lyon, Marseille, Montpellier Cedex 5, Nice Cedex 2, Paris, Rouen Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 560 worldwide
- Run by
- Genmab
See details and how to joinNCT03526835 · EU 2024-513627-16-01 - 1/2. fázisTaking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Pierre-Bénite
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Where
- Marseille, Paris, Paris Cedex 15, Pessac, Poitiers, Reims Cedex, Saint-Priest-en-Jarez, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07284849 · EU 2025-523735-19-00 - No phaseTaking peopleThe French Gut-colo
- Where
- Bobigny
- Életkor
- 50 év to 75 év
- People
- 2500
- Run by
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
See details and how to joinNCT06174233 - 1. fázisTaking peopleA Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Where
- Bordeaux, Lyon, Pierre-Bénite, Villejuif
- Életkor
- 18 év and over
- People
- 404 worldwide
- Run by
- Astellas Pharma Inc
See details and how to joinNCT07094204 · EU 2025-522082-29-00 - 2. fázisTaking peopleA Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Where
- Lille, Lyon, Nantes, Paris, Poitiers
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- AbbVie
See details and how to joinNCT06820463 · EU 2024-512981-33-00 - 3. fázisNot yet taking people in FranciaországStudy of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
- Where
- Avignon Cedex 9, Brest, Caen Cedex 5, Dijon, La Chaussee St Victor, Lyon, Marseille, Montpellier Cedex 5, Nantes, Paris, Pierre-Bénite, Reims, Rennes, Saint-Herblain Cedex, Strasbourg, Tours
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Genmab A/S
See details and how to join2026-525883-17-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Besancon Cedex, Bordeaux, Bordeaux Cedex, Dijon, Lyon, Montpellier Cedex 5, Paris, Rennes Cedex, Saint-Herblain Cedex, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - No phaseTaking peopleImpact of a Multidisciplinary Approach in the Perioperative Geriatrics Unit on Functional Status of Patients Aged 70 and Over Operated on for Colorectal Cancer
- Where
- Nîmes
- Életkor
- 70 év and over
- People
- 90
- Run by
- Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT05993923